Female Reproductive System Carcinoma — Research

Female Reproductive System Carcinoma — Research · CancerIndex

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

pubmedComputed3 windows · counts computed by CancerIndex from PubMed E-utilities; the exact query is stored with each count.

Window	Period	Exact query	Computed	Source
All time	… → 2026-09-11	`("Female Reproductive System Carcinoma"[tiab])`	2026-09-11	pubmed
Last 5 years	2021-01-01 → 2026-12-31	`("Female Reproductive System Carcinoma"[tiab]) AND (2021/01/01:2026/12/31[dp])`	2026-09-11	pubmed
Last 12 months	2025-09-11 → 2026-09-11	`("Female Reproductive System Carcinoma"[tiab]) AND (2025/09/11:2026/09/11[dp])`	2026-09-11	pubmed

Data updated 19 days agoSource updated unknownsource: pubmed E-utilities

Literature

Linked publications (44)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 1–25 of 44 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer.
· N Engl J Med · 2016 · PMID 27717299 · validated civic_curation pubmed
Recurrent SMARCA4 mutations in small cell carcinoma of the ovary.
· Nat Genet · 2014 · PMID 24658004 · validated cbioportal_study pubmed
Gene amplification CCNE1 is related to poor survival and potential therapeutic target in ovarian cancer.
· Cancer · 2010 · PMID 20336784 · validated civic_curation pubmed
Racial differences in the overexpression of epidermal growth factor type II receptor (HER2/neu): a major prognostic indicator in uterine serous papillary cancer.